Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.740
-0.273 (-9.06%)
Jun 16, 2025, 1:10 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Cell-based Therapeutics
2.54M
Log In
Log In
Log In
Log In
Upgrade
Cell-based Therapeutics Growth
48.80%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
2.54M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
48.80%
Log In
Log In
Log In
Log In
Upgrade